AI assistant
Sending…
IRADIMED CORP — Director's Dealing 2022
Oct 13, 2022
32324_dirs_2022-10-13_ac1593c1-b2b8-4953-b39e-b36aa6066adf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-10-04
Reporting Person: Scharen-Guivel Hilda Frederique (N/A)
More from IRADIMED CORP
Interim / Quarterly Report
2026
May 1
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Feb 13
Regulatory Filings
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 13
Director's Dealing
2026
Jan 6